Dyne Therapeutics, Inc. logo

Dyne Therapeutics, Inc. (DYN) Q1 2026 Earnings

DYN·Reported May 11, 2026·Before market open

Diluted EPS came in at $-0.73 (+30.5% YoY), beat the $-0.77 consensus by $0.04.

Diluted EPS
$-0.73beat by $0.04
Consensus: $-0.77
SEC

SEC Filings

Earnings release8-K · 0001193125-26-215720
Quarterly report10-Q · 0001193125-26-215702

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about Dyne Therapeutics, Inc.'s Q1 2026 earnings report.

Dyne Therapeutics, Inc. (DYN) reported Q1 2026 earnings on May 11, 2026 before market open.

Dyne Therapeutics, Inc. reported diluted EPS of $-0.73 for Q1 2026.

EPS beat the consensus estimate of $-0.77 by $0.04.

Compared to the same quarter a year prior, diluted EPS grew 30.5% from $-1.05.

You can read the 8-K earnings release (0001193125-26-215720) and the 10-Q periodic report (0001193125-26-215702) directly on SEC EDGAR. The filing index links above go to sec.gov.